AnaptysBio (ANAB)
(Delayed Data from NSDQ)
$25.07 USD
-0.40 (-1.57%)
Updated May 17, 2024 04:00 PM ET
After-Market: $25.01 -0.06 (-0.24%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
AnaptysBio, Inc. [ANAB]
Reports for Purchase
Showing records 81 - 100 ( 154 total )
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Partnered Dostarlimab Progress Positive, Awaiting ECLIPSE and ANB019 Updates
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
4Q19 Financials; Quiet Days as Early Stage Pipeline Advances
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
D/g to NEUTRAL; Etokimab Miss Disappointing, but ANABs Still Better than Cash
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Revisiting Setup into Topline Ph 2b ATLAS Readout in Atopic Dermatitis
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
ANB019 First Patients Positive, Next Update in 2020
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
Company: AnaptysBio, Inc.
Industry: Medical - Biomedical and Genetics
2019 PacGrow Healthcare Conference: Day 1 Recap
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D